InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by HASTINGS PAUL J, Chairman & CEO. Director active across 2 companies, notably Pacira BioSciences, Inc.. Aggregated, 12 filings have been published. Total volume traded: €661k. The latest transaction was filed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations12 total
019,500 shares0
Common Stock
SEC:0001209191-22-038532:0·
01,160 shares0
Common Stock
SEC:0001209191-22-035223:0·
041,900 shares0
Common Stock
SEC:0001209191-22-003759·
041,900 shares0
Common Stock
SEC:0001209191-22-003759:0·
€194,0558,277 shares@ €23.4450.10% mcap65.1% of flow
Common Stock
SEC:0000899243-21-038637·
€194,0558,277 shares@ €23.4450.10% mcap32.6% of flow
Common Stock
SEC:0000899243-21-038637:0·
€103,9644,693 shares@ €22.15310.055% mcap34.9% of flow
Common Stock
SEC:0000899243-21-025505·
€103,9644,693 shares@ €22.15310.055% mcap17.4% of flow
Common Stock
SEC:0000899243-21-025505:0·
01,066 shares0
Common Stock
SEC:0001209191-21-040084:0·
01,066 shares0
Common Stock
SEC:0001209191-21-040084·
€32,292630 shares@ €51.25690.0030% mcap100.0% of flow
Common Stock
SEC:0001209191-21-038878·
€32,292630 shares@ €51.25690.0030% mcap50.0% of flow
Common Stock
SEC:0001209191-21-038878:0·
12 of 12 declarations
About HASTINGS PAUL J
Paul J. Hastings serves as CEO and Director of Pacira BioSciences, Inc. and Nkarta, Inc. In these roles, he is responsible for the strategic and operational leadership of the companies. Hastings plays a crucial role in managing operations and business development, ensuring that the companies achieve their growth objectives.
